Diabetes inpatient care during COVID-19
A new Diabetes UK review into diabetes inpatient care during COVID-19 has revealed that disruption to inpatient diabetes services created positive environments and opportunities...
The King’s Fund comments on NHS performance data
The King's Fund has commented on the monthly NHS performance data on accident and emergency, referral to treatment and diagnostics which shows the impact...
Long-term COVID-19 symptoms in patients and doctors
Data released today as part of the BMA’s latest survey of doctors during the pandemic reveals significant levels of long-term COVID-19 symptoms in patients...
Atrial Fibrillation Toolkit: Tackling avoidable strokes to save lives and strain on the NHS
The AHSN Network of 15 Academic Health Science Networks in England has launched the national ‘Atrial Fibrillation Toolkit’ (www.aftoolkit.co.uk) to address barriers to stroke...
Primary care networks and mental health services post COVID-19
Joint working between primary care networks and providers of mental health services must accelerate if the NHS is to help the huge increase in...
Common chronic pain treatments ‘can do more harm than good’
A number of commonly used drug treatments for chronic primary pain have little or no evidence that they work and shouldn’t be prescribed, NICE...
Roll out of rapid coronavirus tests ahead of winter
Millions of rapid coronavirus tests will be rolled out to hospitals, care homes and labs across the UK to increase testing capacity ahead of...
Accelerated use of electronic prescribing
Deborah Evans, Managing Director of Pharmacy Complete, looks at the instruction to stay at home, GP surgeries closing their doors and consumers rethinking how...
New study into link between IBD and colorectal cancers
In a new study, researchers have compared diseased colon tissue with healthy tissue to better understand how IBD is linked to an increased risk of...
Bridging the gap in heart failure awareness
The World Heart Federation (WHF) and AstraZeneca have published a new Heart Failure Gap Report bridging the gap in heart failure awareness.
While heart failure...
Latest articles
Antibiotic Research UK launches small research grants programme
Antibiotic Research UK (ANTRUK), the world’s first charity tackling bacterial antibiotic resistance, has just launched its largest grants programme to date, the 2021 Small...
First AI-designed Immuno-Oncology drug to enter clinical trials
Discovered within 8 months of project initiation, the first AI-designed molecule for Immuno-Oncology is to enter human clinical trials. The A2a receptor antagonist, which is in development...
The first self-administered B-cell therapy for patients with relapsing forms of MS
Novartis receives European and UK licence for Kesimpta®▼(ofatumumab) Ofatumumab is a self-administered targeted B-cell depleting treatment option for adult patients living with relapsing forms of...
Popular articles
New Normal, New Thinking: Life Post COVID-19
New thinking will be required to adapt to the new normal life post COVID-19. I hate to start this article on a negative note, but...
The first self-administered B-cell therapy for patients with relapsing forms of MS
Novartis receives European and UK licence for Kesimpta®▼(ofatumumab) Ofatumumab is a self-administered targeted B-cell depleting treatment option for adult patients living with relapsing forms of...
Study shows anti-parasitic drug ivermectin kills coronavirus within 48 hours
A collaborative study led by the Monash Biomedicine Discovery Institute (BDI) with the Peter Doherty Institute of Infection and Immunity (Doherty Institute), a joint...
New COVID-19 test reduces testing time from 30 minutes to five
University of Birmingham researchers have invented a COVID-19 test that reduces testing time from 30 minutes to under five, whilst still delivering accurate results. The...
First AI-designed Immuno-Oncology drug to enter clinical trials
Discovered within 8 months of project initiation, the first AI-designed molecule for Immuno-Oncology is to enter human clinical trials. The A2a receptor antagonist, which is in development...